1.Revised PhilHealth case rates for hospitalization for acute coronary syndrome in the Philippines
Felix Eduardo R. Punzalan ; Noemi S. Pestañ ; o ; April Ann A. Bermudez-delos Santos ; Bernadette A. Tumanan-Mendoza ; Victor L. Mendoza ; Eric Oliver D. Sison ; Karen Amoloza-De Leon ; Eugenio B. Reyes ; Nashiba M. Daud ; Maria Grethel C. Dimalala-Lardizabal ; Orlando R. Bugarin ; Rodney M. Jimenez ; Domicias L. Albacite ; Ma. Belen A. Balagapo ; Elfred M. Batalla ; Jonathan James G. Bernardo ; Helen Ong Garcia ; Amibahar J. Karim ; Gloria R. Lahoz ; Neil Wayne C. Salces
Philippine Journal of Cardiology 2022;50(2):16-25
BACKGROUND
Hospitalization for acute coronary syndrome (ACS) has epidemiologic and economic burden. The coverage for hospitalization in the local setting is much less than the actual costs. Many patients do not consent to or avail of the optimal and timely management because of financial challenges.
OBJECTIVESThe paper aimed to propose revised PhilHealth case rates/packages for ACS, namely: 1) unstable angina (UA), 2) non-ST-elevation myocardial infarction (NSTEMI), and 3) STelevation myocardial infarction (STEMI).
METHODSA consensus panel was organized to provide inputs such as cost and other matters pertaining to the revision of the PhilHealth ACS case rates/packages. The results of the cost of hospitalization of the different ACS conditions derived from a study on hospitalization cost for ACS were presented to the panel. Several focused group discussions were held afterward for propositioning new case rates through votation and by nominal group technique, using the costs from the study as the bases of rate adjustment.
RESULTSFinal costs agreed upon by the consensus panel for medical management alone for UA, NSTEMI, and STEMI were adjusted or amended in increments of Php 20,000, (80,000, 100,000, and 120,000, respectively). Thrombolysis of a patient admitted for STEMI increased the cost to Php 140,000. An additional cost of Php 150,000 was added on top of the cost for medical management and coronary angiogram for NSTE- ACS for PCI with use of a single stent. For STEMI, the same category had an additional cost of Php 180,000. For each additional stent used for all clinical scenarios undergoing PCI, Php 65,000 was added, to cover up to a total of 3 stents.
CONCLUSIONBased on the consensus process with Philippine Heart Association ACS panelists, the cost proposed ranges from 80,000 pesos to 530,000 pesos depending on the clinical scenarios.
Acute Coronary Syndrome
Result Analysis
Print
Save
E-mail